These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12700947)

  • 1. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
    Baral RN; Saha A; Chatterjee S; Foon KA; Krieg A; Weiner GJ; Bhattacharya-Chatterjee M
    Cancer Immunol Immunother; 2003 May; 52(5):317-27. PubMed ID: 12700947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
    Saha A; Baral RN; Chatterjee SK; Mohanty K; Pal S; Foon KA; Primus FJ; Krieg AM; Weiner GJ; Bhattacharya-Chatterjee M
    Cancer Immunol Immunother; 2006 May; 55(5):515-27. PubMed ID: 16044253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen.
    Pervin S; Chakraborty M; Bhattacharya-Chatterjee M; Zeytin H; Foon KA; Chatterjee SK
    Cancer Res; 1997 Feb; 57(4):728-34. PubMed ID: 9044852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
    Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
    Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
    Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
    Weiner GJ; Liu HM; Wooldridge JE; Dahle CE; Krieg AM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10833-7. PubMed ID: 9380720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.
    Bhattacharya-Chatterjee M; Mukerjee S; Biddle W; Foon KA; Köhler H
    J Immunol; 1990 Oct; 145(8):2758-65. PubMed ID: 1698862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen mimicry by an anti-idiotypic antibody single chain variable fragment.
    Tripathi PK; Qin H; Deng S; Xu C; Bhattacharya-Chatterjee M; Foon KA; Chatterjee SK
    Mol Immunol; 1998 Sep; 35(13):853-63. PubMed ID: 9839554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice.
    Saha A; Bhattacharya-Chatterjee M; Foon KA; Celis E; Chatterjee SK
    Int J Cancer; 2009 Feb; 124(4):877-88. PubMed ID: 19035460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG-oligodeoxynucleotide induces potent antitumor immunity.
    Woo SJ; Kim CH; Park MY; Kim HS; Sohn HJ; Park JS; Kim HJ; Oh ST; Kim TG
    Cancer Sci; 2008 May; 99(5):1034-9. PubMed ID: 18294279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen.
    Chakraborty M; Foon KA; Kohler H; Bhattacharya-Chatterjee M
    J Immunother Emphasis Tumor Immunol; 1995 Aug; 18(2):95-103. PubMed ID: 8574471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.
    Li WM; Dragowska WH; Bally MB; Schutze-Redelmeier MP
    Vaccine; 2003 Jul; 21(23):3319-29. PubMed ID: 12804863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.
    Foon KA; Chakraborty M; John WJ; Sherratt A; Köhler H; Bhattacharya-Chatterjee M
    J Clin Invest; 1995 Jul; 96(1):334-42. PubMed ID: 7615803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
    Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL
    Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity.
    Payton LA; Lewis JD; Byrne JA; Bright RK
    Cancer Immunol Immunother; 2008 Jun; 57(6):799-811. PubMed ID: 17962942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
    J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.